Molecular Formula | C25H29N3O3 |
Molar Mass | 419.52 |
Density | 1.134±0.06 g/cm3(Predicted) |
Boling Point | 567.9±50.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
pKa | 8.86±0.10(Predicted) |
Storage Condition | 2-8°C |
In vitro study | The kinase most highly inhibited by LDN-214117 is ALK2 (IC50, 24 nM), followed by TNIK, RIPK2, and ABL1. LDN-214117 demonstrates selective inhibition of ALK2 and ALK1 in preference to ALK3 kinase activity. LDN-214117 exhibits relatively selective inhibition of BMP6 versus BMP2 or BMP4. In a cell-based assay, LDN-214117 exhibits a selective inhibition on BMP6 with IC50 of approximately 100 nM, and 164-fold selectivity for BMP6 versus TGF-β1. |
Hazard Symbols | T - Toxic |
Risk Codes | 25 - Toxic if swallowed |
Safety Description | 45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.384 ml | 11.918 ml | 23.837 ml |
5 mM | 0.477 ml | 2.384 ml | 4.767 ml |
10 mM | 0.238 ml | 1.192 ml | 2.384 ml |
5 mM | 0.048 ml | 0.238 ml | 0.477 ml |